Revugam 25mg Tablet
Marketer
Bharat Serums & Vaccines Ltd
Salt Composition
Eltrombopag (25mg)
Overview Revugam 25mg Tablet
Romiplostim 25mg tablets are indicated for individuals with low platelet counts stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV) infection. This medication also addresses severe aplastic anemia. Romiplostim is a thrombopoietin receptor agonist, functioning by boosting platelet production. Platelets are crucial for hemostasis. Always adhere precisely to your physician's prescribed dosage and regimen. It can be administered on an empty stomach and should be swallowed whole; avoid crushing or chewing. Report any known drug allergies to your doctor. Common adverse effects include nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Discuss any bothersome side effects with your doctor; management strategies may be available. Prior to commencing treatment, disclose all pre-existing health issues and any other medications you're using. Dosage modification might be necessary for patients with liver impairment; consult your doctor.
Uses of Revugam 25mg Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; Management of critical bone marrow failure
Major Benefits of Revugam 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Revugam 25mg Tablet on an empty stomach.
Common Side effects of Revugam 25mg Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Revugam 25mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Revugam 25mg Tablet on an empty stomach.
How Revugam 25mg Tablet works:
Trombopoietin receptor activator Revugam 25mg tablets enhance platelet production, thus mitigating or preventing hemorrhaging.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining Revugam 25mg Tablet with alcohol is undetermined. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Revugam 25mg Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
The use of Revugam 25mg Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Revugam 25mg Tablet, which can induce dizziness and other side effects reducing alertness.
KidneySAFE IF PRESCRIBED
Revugam 25mg tablets are considered safe for use by individuals with kidney disease, and no dosage modification is typically necessary. Nevertheless, disclosure of kidney disease to your physician is recommended. Routine monitoring of kidney function is advisable during treatment with this medication.
LiverCAUTION
Individuals with hepatic impairment should use Revugam 25mg Tablets cautiously. Dosage modification of Revugam 25mg Tablets may be necessary. Physician consultation is advised.
What if you forget to take Revugam 25mg Tablet :
Omit any missed dose of Revugam 25mg Tablet and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Revugam 25mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Diphenyl Compounds |
| Potential for Dependence | None. |
| Type of Medication | Hematological |
| Mechanism of Action | Stimulator of thrombopoiesis |




